BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32060685)

  • 1. [Cartilage tumors: morphology, genetics, and current aspects of target therapy].
    Roessner A; Smolle M; Schoeder V; Haybaeck J
    Pathologe; 2020 Mar; 41(2):143-152. PubMed ID: 32060685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
    de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
    Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cartilage tumors : Pathology and radiomorphology].
    Uhl M; Herget G; Kurz P
    Radiologe; 2016 Jun; 56(6):476-88. PubMed ID: 27233920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.
    Altay M; Bayrakci K; Yildiz Y; Erekul S; Saglik Y
    J Orthop Sci; 2007 Sep; 12(5):415-23. PubMed ID: 17909925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cartilage-forming tumors.
    Qasem SA; DeYoung BR
    Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
    Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
    Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
    Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics.
    Romeo S; Hogendoorn PC; Dei Tos AP
    Adv Anat Pathol; 2009 Sep; 16(5):307-15. PubMed ID: 19700940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
    Cohen JN; Solomon DA; Horvai AE; Kakar S
    Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
    Bovée JV; Hogendoorn PC; Wunder JS; Alman BA
    Nat Rev Cancer; 2010 Jul; 10(7):481-8. PubMed ID: 20535132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cartilage tumors. Classification, conditions for biopsy and histologic characteristics].
    Delling G; Jobke B; Burisch S; Werner M
    Orthopade; 2005 Dec; 34(12):1267-81; quiz 1281-2. PubMed ID: 16322881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
    Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
    Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures.
    Zuntini M; Salvatore M; Pedrini E; Parra A; Sgariglia F; Magrelli A; Taruscio D; Sangiorgi L
    Clin Genet; 2010 Dec; 78(6):507-16. PubMed ID: 20662852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of bone tumors.
    Bertoni F; Bacchini P
    Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
    Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
    Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Cartilage-Forming Tumors.
    Hameed M
    Surg Pathol Clin; 2021 Dec; 14(4):605-617. PubMed ID: 34742483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
    Aigner T
    Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
    Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
    J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.